These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6265561)

  • 21. Antibody to varicella-zoster virus-induced membrane antigen: immunoperoxidase assay with air-dried target cells.
    Haikin H; Leventon-Kriss S; Sarov I
    J Infect Dis; 1979 Oct; 140(4):601-4. PubMed ID: 229177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varicella-zoster virus-specific immunity after herpes zoster.
    Hayward A; Levin M; Wolf W; Angelova G; Gilden D
    J Infect Dis; 1991 Apr; 163(4):873-5. PubMed ID: 1849165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster.
    Brunell PA; Gershon AA; Uduman SA; Steinberg S
    J Infect Dis; 1975 Jul; 132(1):49-54. PubMed ID: 169308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme-linked immunosorbent assay for detection of virus-specific IgM antibodies to varicella-zoster virus.
    Hacham M; Leventon-Kriss S; Sarov I
    Intervirology; 1980; 13(4):214-22. PubMed ID: 6248482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving the varicella-zoster virus: IgG radioimmunoassay procedure by the use of purified antigen.
    Clarke JR; Ronalds CJ; Kangro HO; Heath RB
    J Virol Methods; 1984 Feb; 8(1-2):1-8. PubMed ID: 6323503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rapid radioimmunoassay using 125I-labeled staphylococcal protein A for antibody to varicella-zoster virus.
    Richman DD; Cleveland PH; Oxman MN; Zaia JA
    J Infect Dis; 1981 May; 143(5):693-9. PubMed ID: 6263987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen.
    Takahashi M; Iketani T; Sasada K; Hara J; Kamiya H; Asano Y; Baba K; Shiraki K
    J Infect Dis; 1992 Aug; 166 Suppl 1():S58-62. PubMed ID: 1320651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody response to varicella-zoster virus surface glycoproteins in chickenpox and shingles.
    Larkin M; Heckels JE; Ogilvie MM
    J Gen Virol; 1985 Aug; 66 ( Pt 8)():1785-93. PubMed ID: 2991441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific immunoglobulin responses after varicella and herpes zoster.
    Cradock-Watson JE; Ridehalgh MK; Bourne MS
    J Hyg (Lond); 1979 Apr; 82(2):319-36. PubMed ID: 219110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgG subclass distribution among antibodies to varicella-zoster virus in human varicella/zoster immunoglobulin preparations and the corresponding donor plasma.
    Møyner K; Michaelsen TE
    J Biol Stand; 1988 Jul; 16(3):157-64. PubMed ID: 2844824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subclass distribution of the serum and intrathecal IgG antibody response in varicella-zoster virus infections.
    Echevarría JM; Téllez A; Martínez-Martín P
    J Infect Dis; 1990 Sep; 162(3):621-6. PubMed ID: 2167334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of polyclonal antisera against cytomegalovirus and varicella-zoster virus by use of affinity-purified viral antigens.
    Ukkonen P
    APMIS; 1989 Mar; 97(3):267-73. PubMed ID: 2540778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
    Sauerbrei A; Wutzler P
    Clin Lab; 2009; 55(1-2):1-7. PubMed ID: 19350844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined use of complement and anti-immunoglobulin in an enhanced neutralization assay for antibodies to varicella-zoster virus.
    Krah DL; Provost PJ; Ellis RW
    J Virol Methods; 1995 Jun; 53(2-3):176-87. PubMed ID: 7673386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects.
    Giller RH; Winistorfer S; Grose C
    J Infect Dis; 1989 Dec; 160(6):919-28. PubMed ID: 2555419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The production of varicella Zoster virus antiserum in laboratory animals. Brief report.
    Wroblewska Z; Devlin M; Reilly K; van Trieste H; Wellish M; Gilden DH
    Arch Virol; 1982; 74(2-3):233-8. PubMed ID: 6299237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation.
    Yamazaki R; Nakasone H; Tanaka Y; Sato M; Terasako K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1013-20. PubMed ID: 23583826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of specific antibodies by CSF lymphocytes in patients with herpes zoster.
    Forsberg P; Frydén A; Kam-Hansen S
    Lancet; 1984 Feb; 1(8373):404-5. PubMed ID: 6141474
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170.
    Arvin AM; Kinney-Thomas E; Shriver K; Grose C; Koropchak CM; Scranton E; Wittek AE; Diaz PS
    J Immunol; 1986 Aug; 137(4):1346-51. PubMed ID: 3016094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content.
    Bergen RE; Diaz PS; Arvin AM
    J Infect Dis; 1990 Nov; 162(5):1049-54. PubMed ID: 2172393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.